Palisade Bio (PALI) Cash from Investing Activities Growth (1y) (2011 - 2021)
Palisade Bio (PALI) Cash from Investing Activities Growth (1y) (2011 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Palisade Bio |
357.48 Mn |
227.91 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2021 |
-34,900.00% |
| Dec 31, 2018 |
-320.10% |
| Dec 31, 2017 |
99.99% |
| Dec 31, 2016 |
-97.06% |
| Jun 30, 2016 |
-8.61% |
| Mar 31, 2016 |
7,721.50% |
| Dec 31, 2015 |
-3,258.65% |
| Sep 30, 2015 |
10,607.29% |
| Jun 30, 2015 |
45.19% |
| Mar 31, 2015 |
99.35% |
| Dec 31, 2014 |
17.64% |
| Sep 30, 2014 |
54.09% |
| Jun 30, 2014 |
-20.42% |
| Mar 31, 2014 |
-15,623.64% |
| Dec 31, 2013 |
-38.76% |
| Sep 30, 2013 |
-436.20% |
| Jun 30, 2013 |
-16.43% |
| Mar 31, 2013 |
-236.54% |
| Dec 31, 2012 |
-9.46% |
| Sep 30, 2012 |
70.83% |
